Cargando…

Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature

BACKGROUND: Ongoing alcohol use is strongly associated with progressive liver damage and higher mortality in patients with alcohol‐related liver disease (ArLD). Reduction in alcohol use is therefore the cornerstone of treatment to improve the long‐term outcome of these patients. However, a large pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Horrell, Jane, Callaghan, Lynne, Dhanda, Ashwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543176/
https://www.ncbi.nlm.nih.gov/pubmed/35766348
http://dx.doi.org/10.1111/acer.14895
_version_ 1784804314188873728
author Horrell, Jane
Callaghan, Lynne
Dhanda, Ashwin
author_facet Horrell, Jane
Callaghan, Lynne
Dhanda, Ashwin
author_sort Horrell, Jane
collection PubMed
description BACKGROUND: Ongoing alcohol use is strongly associated with progressive liver damage and higher mortality in patients with alcohol‐related liver disease (ArLD). Reduction in alcohol use is therefore the cornerstone of treatment to improve the long‐term outcome of these patients. However, a large proportion of patients continue to use alcohol and do not access or engage with alcohol treatment services after a diagnosis of ArLD. We reviewed the literature on factors associated with ongoing alcohol consumption among patients with ArLD to identify barriers or facilitators to their accessing alcohol treatment. METHODS: A search of MEDLINE and EMBASE was conducted using search strategies relating to ArLD and the psychosocial factors hypothesized to influence alcohol reduction and/or abstinence. RESULTS: There were few relevant studies pertinent to this population group. Several studies reported a high prevalence of mental health diagnoses associated with the severity of alcohol dependence. Social and environmental factors were shown to be important determinants of alcohol use. Common themes perceived as barriers to treatment from qualitative interviews with ArLD patients across studies included poor communication between the clinical team and patient, lack of symptoms recognized by patients themselves, and perceived loss of control over their condition. CONCLUSIONS: We recommend that future clinical studies of patient cohorts with ArLD include detailed psychosocial assessments to capture information on mental health and social factors. Qualitative studies are required to explore the patient journey pre and post hospital admission, which should focus on identifying facilitators and barriers to accessing treatment. Well‐designed, controlled studies are needed to identify patient, social, and environmental factors associated with relapse to alcohol use after a diagnosis of ArLD. These data will enable us to adapt our support for patients to enhance engagement with services and improve long‐term outcomes.
format Online
Article
Text
id pubmed-9543176
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95431762022-10-14 Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature Horrell, Jane Callaghan, Lynne Dhanda, Ashwin Alcohol Clin Exp Res Critical Review BACKGROUND: Ongoing alcohol use is strongly associated with progressive liver damage and higher mortality in patients with alcohol‐related liver disease (ArLD). Reduction in alcohol use is therefore the cornerstone of treatment to improve the long‐term outcome of these patients. However, a large proportion of patients continue to use alcohol and do not access or engage with alcohol treatment services after a diagnosis of ArLD. We reviewed the literature on factors associated with ongoing alcohol consumption among patients with ArLD to identify barriers or facilitators to their accessing alcohol treatment. METHODS: A search of MEDLINE and EMBASE was conducted using search strategies relating to ArLD and the psychosocial factors hypothesized to influence alcohol reduction and/or abstinence. RESULTS: There were few relevant studies pertinent to this population group. Several studies reported a high prevalence of mental health diagnoses associated with the severity of alcohol dependence. Social and environmental factors were shown to be important determinants of alcohol use. Common themes perceived as barriers to treatment from qualitative interviews with ArLD patients across studies included poor communication between the clinical team and patient, lack of symptoms recognized by patients themselves, and perceived loss of control over their condition. CONCLUSIONS: We recommend that future clinical studies of patient cohorts with ArLD include detailed psychosocial assessments to capture information on mental health and social factors. Qualitative studies are required to explore the patient journey pre and post hospital admission, which should focus on identifying facilitators and barriers to accessing treatment. Well‐designed, controlled studies are needed to identify patient, social, and environmental factors associated with relapse to alcohol use after a diagnosis of ArLD. These data will enable us to adapt our support for patients to enhance engagement with services and improve long‐term outcomes. John Wiley and Sons Inc. 2022-07-08 2022-08 /pmc/articles/PMC9543176/ /pubmed/35766348 http://dx.doi.org/10.1111/acer.14895 Text en © 2022 The Authors. Alcoholism: Clinical & Experimental Research published by Wiley Periodicals LLC on behalf of Research Society on Alcoholism. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Critical Review
Horrell, Jane
Callaghan, Lynne
Dhanda, Ashwin
Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature
title Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature
title_full Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature
title_fullStr Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature
title_full_unstemmed Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature
title_short Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature
title_sort alcohol misuse in patients with alcohol‐related liver disease: how can we do better? a narrative review of the literature
topic Critical Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543176/
https://www.ncbi.nlm.nih.gov/pubmed/35766348
http://dx.doi.org/10.1111/acer.14895
work_keys_str_mv AT horrelljane alcoholmisuseinpatientswithalcoholrelatedliverdiseasehowcanwedobetteranarrativereviewoftheliterature
AT callaghanlynne alcoholmisuseinpatientswithalcoholrelatedliverdiseasehowcanwedobetteranarrativereviewoftheliterature
AT dhandaashwin alcoholmisuseinpatientswithalcoholrelatedliverdiseasehowcanwedobetteranarrativereviewoftheliterature